Evidence of Novel SARS-CoV-2 Variants Circulation in Romania

被引:0
|
作者
Surleac, Marius [1 ,2 ]
Casangiu, Corina [1 ,3 ]
Banica, Leontina [1 ]
Milu, Petre [1 ,4 ]
Florea, Dragos [1 ,4 ]
Sandulescu, Oana [1 ,4 ]
Streinu-Cercel, Anca [1 ,4 ]
Vlaicu, Ovidiu [1 ]
Tudor, Andreea [1 ]
Hohan, Robert [1 ]
Paraschiv, Simona [1 ,4 ]
Otelea, Dan [1 ]
机构
[1] Prof Dr Matei Bals Natl Inst Infect Dis, Str Calistrat Grozovici 1,Sect 2, Bucharest 021105, Romania
[2] Univ Bucharest, Res Inst, Bucharest, Romania
[3] Marie Curie Emergency Clin Hosp, Bucharest, Romania
[4] Carol Davila Univ Med & Pharm, Bucharest, Romania
关键词
SARS-CoV-2; WGS; Spike gene mutation; VOC; 202012; 01; lineage; phylogeny;
D O I
10.1089/aid.2021.0009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New SARS-CoV-2 variants are constantly emerging and putting a strain on public health systems by spreading faster and potentially evading immune protection through vaccination. One of these strains is the B.1.1.7 variant that has initially been described in the United Kingdom and has subsequently spread to several countries. Monitoring the amplification of the S gene-a major hotspot for molecular evolution-by reverse transcription polymerase chain reaction (RT-PCR) allows rapidly screening for such variants. This report describes the detection of sequence variants in Romania by using this strategy followed by next-generation sequencing of the entire genome for confirmation and further characterization. One B.1.1.7 and three B.1.258 sequences were confirmed. Each of these strains presented additional mutations with possible impact on the replicative capacity. Public health strategies should be devised to ensure molecular monitoring of SARS-CoV-2 evolution during the pandemic and allow adequate and rapid reaction.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 50 条
  • [1] Characteristics of SARS-CoV-2 Infections in Israeli Children During the Circulation of Different SARS-CoV-2 Variants
    Somekh, Ido
    Stein, Michal
    Karakis, Isabella
    Simoes, Eric A. F.
    Somekh, Eli
    JAMA NETWORK OPEN, 2021, 4 (09) : E2124343
  • [2] No evidence of SARS-CoV-2 circulation before identification of the first Swiss SARS-CoV-2 case
    Lhopitallier, Loic
    Brahier, Thomas
    Opota, Onya
    Kronenberg, Andreas
    Mueller, Yolanda
    Huegli, Olivier
    Jaton, Katia
    Boillat-Blanco, Noemie
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)
  • [3] The Emergence and Spread of Novel SARS-CoV-2 Variants
    Yi, Huaimin
    Wang, Jin
    Wang, Jiong
    Lu, Yuying
    Zhang, Yali
    Peng, Ruihao
    Lu, Jiahai
    Chen, Zeliang
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [4] Emergence of novel SARS-CoV-2 variants in the Netherlands
    Urhan, Aysun
    Abeel, Thomas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Emergence of novel SARS-CoV-2 variants in the Netherlands
    Aysun Urhan
    Thomas Abeel
    Scientific Reports, 11
  • [6] VARIANTS OF SARS-COV-2
    Krzywinski, Martin
    AMERICAN SCIENTIST, 2022, 110 (02) : 76 - 76
  • [7] On the SARS-CoV-2 Variants
    Scarpa, Fabio
    Branda, Francesco
    Petrosillo, Nicola
    Ciccozzi, Massimo
    INFECTIOUS DISEASE REPORTS, 2024, 16 (02) : 289 - 297
  • [8] Variants of SARS-CoV-2
    Lauring, Adam S.
    Malani, Preeti N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (09): : 880 - 880
  • [9] SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
    Dao, Thi Loi
    Hoang, Van Thuan
    Colson, Philippe
    Lagier, Jean Christophe
    Million, Matthieu
    Raoult, Didier
    Levasseur, Anthony
    Gautret, Philippe
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [10] Novel SARS-CoV-2 variants: the pandemics within the pandemic
    Boehm, Erik
    Kronig, Ilona
    Neher, Richard A.
    Eckerle, Isabella
    Vetter, Pauline
    Kaiser, Laurent
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1109 - 1117